Compare Exicure (2H0) vs. Competitors
1 Followers
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| DE:2H0Exicure | EUR 0.75 | EUR 5.87M | -0.76 | -79.07% | ― | Unlock the DE:2H0 analyst price target with TipRanks Premium | DE:2H0 | Unlock the DE:2H0 top-analyst price target with TipRanks Premium | ||
| UNCYUnicycive Therapeutics | $3.75 | $100.00M | -2.24 | -15.54% | Strong Buy | Unlock the UNCY analyst price target with TipRanks Premium | DE:2H0 vs UNCY | Unlock the UNCY top-analyst price target with TipRanks Premium | ||
| CRBUCaribou Biosciences | $0.44 | $49.25M | -0.41 | -79.54% | Moderate Buy | Unlock the CRBU analyst price target with TipRanks Premium | DE:2H0 vs CRBU | Unlock the CRBU top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| DE:2H0 | Exicure | 0.74 | -2.71 | -78.47% | |
| UNCY | Unicycive Therapeutics | 3.75 | -0.73 | -16.29% | |
| CRBU | Caribou Biosciences | 0.44 | -1.70 | -79.25% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
